Search
Disease control, safe medications critical to pregnancies for women with rheumatic disease: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-women-with-rheumatic-disease.html
Pregnant women with active rheumatic disease carry a higher risk of adverse outcomes than the general population including hypertension, preeclampsia, higher cesarean section rate, small for gestational aged infants, preterm delivery, and fetal loss.
Breast cancer drug benefits broader group of patients, trial shows: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-breast-cancer-drug.html
A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who have other genetic mutations.
UT Southwestern study highlights racial bias factors in physician assistant training: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-racial-bias-factors.html
Physician assistant (PA) programs need to actively engage Black/African American students to help address issues of systemic racism, according to a new study.
New Intracept ablation proves effective for quelling low back pain: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/september-intracept-low-back-pain.html
UT Southwestern Spine Center is now offering a minimally invasive ablation procedure to provide relief for low back pain caused by traumatic injury or degeneration of the vertebral endplates.
UT Southwestern’s nationally ranked geriatric care receives international exemplar status: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-nationally-ranked-geriatric-care.html
UT Southwestern Medical Center has received exemplar status by the Nurses Improving Care for Healthsystem Elders (NICHE).
New recommendations aim to ease patient access to lung cancer clinical trials: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-lung-cancer-clinical-trials.html
A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill clinical trials and enroll sufficiently diverse groups of patients for results to reflect the broader population, in part because of stringent guidelines on who can participate.
UTSW researchers find no decrease in preterm births with vaginal progesterone: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-preterm-births-with-vaginal-progesterone.html
Vaginal progesterone, a hormone treatment considered the standard of care for preventing preterm birth in at-risk pregnant women, may not be effective, according to UT Southwestern researchers.
How to protect yourself against summer urinary tract infections: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-summer-urinary-tract-infections.html
Summertime means lots of opportunities for fun in the sun. But this year’s high temperatures also bring an increased risk of dehydration that can cause urinary tract infections (UTIs), said Maude Carmel, M.D., Associate Professor of Urology at UT Southwestern Medical Center.
Business consultant and investor Debra Hunter Johnson named Chair of UT Southwestern President’s Advisory Board: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/february-chair-debra-hunter-johnson.html
Business consultant, attorney, and investor Debra Hunter Johnson, founder of Reciprocity Consulting Group, will chair the UT Southwestern Medical Center President’s Advisory Board for the 2023-2025 term.
UTSW researchers map activity of inherited gene variants linked to prostate cancer: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-gene-variants-linked-to-prostate-cancer.html
UT Southwestern researchers have identified the molecular function of 87 inherited genetic variants that affect the risk of prostate cancer, and the majority appear to control the activity of genes located far away from the risk variants themselves.